Applications have opened for the ninth cohort of KQ Labs, the national accelerator for data‑driven health start‑ups delivered ...

Novartis has secured European Commission approval for Itvisma for the treatment of children aged two years and older, as well ...

R1 Therapeutics has formed a scientific advisory board comprising seven internationally recognised nephrology experts as the ...

AlzeCure Pharma has signed an out‑licensing and collaboration agreement with Danish biotech QuantumCell ApS, granting global rights to the company’s NeuroRestore platform, inc ...

Agomab Therapeutics has announced the design of its phase 2b NOV‑ERA study of ontunisertib in fibrostenosing Crohn’s disease, ...

The European Commission has approved Sanofi’s Cenrifki (tolebrutinib) for adults with secondary progressive multiple ...

Racura Oncology has treated the first patient in its phase 1 HARNESS‑1 clinical trial of RC220 for EGFR‑mutant non‑small cell ...

Company secures first commercial product with data for active and chronic TED Viridian Therapeutics has received US FDA approval for Lumvoa (veligrotug-vvze) for thyroid eye disease, marking the first ...

M42’s Insights Research Organization and Solutions has launched the UAE’s first genomics-driven clinical trial, working with the Department of Health – Abu Dhabi and Halia T ...

Lundbeck will present new migraine data at the European Academy of Neurology Congress 2026, taking place from 27–30 June in ...

First immunotherapy approved for LACC in England offers new treatment option for women MSD has welcomed the National Institute for Health and Care Excellence’s recommendation of pembrolizumab ...

When looking to treat erectile dysfunction, there are two commonly used treatment options available for patients. These are Viagra and sildenafil: two similar but distinct types of medication. Both ...